Texas · 89th Legislature (2025) · Bill
HB 5147: Relating to investigational stem cell treatment.
Passed one chamber Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 5147 is a bill introduced in the Texas House on March 14, 2025. According to its official title, it concerns: Relating to investigational stem cell treatment. Primary sponsor: King, Tom Oliverson (Republican), Suleman Lalani (Democratic), Lauren Simmons (Democratic), Tan Parker (Republican). It lists 1 additional sponsor. Most recent recorded action (May 21, 2025): Left pending in committee.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 3 · Republican 2
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| King | Primary sponsor | Not applicable (committee) | — | — |
| Tom Oliverson | Primary sponsor | Republican | House | 130 |
| Suleman Lalani | Primary sponsor | Democratic | House | 76 |
| Lauren Simmons | Primary sponsor | Democratic | House | 146 |
| Tan Parker | Primary sponsor | Republican | Senate | 12 |
| Aicha Davis | Co-sponsor | Democratic | House | 109 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Left pending in committee
- Testimony taken in committee
- Considered in public hearing
- Scheduled for public hearing on . . .
- Posting rule suspended
- Referred to Health & Human Services
- Read first time
- Received from the House
- Reported engrossed
- Statement(s) of vote recorded in Journal
- Record vote
- Passed
Showing 12 most recent of 31 actions. Full history